Clinical trials
Completed Phase 1 Eye Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2009 | 1 |
| 2010 | 3 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 2 |
| Active Biotech AB | 1 |
| Adverum Biotechnologies, Inc. | 1 |
| Amakem, NV | 1 |
| Genzyme, a Sanofi Company | 1 |
| Kukje Pharma | 1 |
| LENZ Therapeutics, Inc | 1 |
| M.D. Anderson Cancer Center | 1 |
| Medical University of Lublin | 1 |
| National Eye Institute (NEI) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eye Diseases | 18 |
| Macular Degeneration | 6 |
| Retinal Degeneration | 6 |
| Glaucoma | 5 |
| Retinal Diseases | 4 |
| Ocular Hypertension | 3 |
| Blindness | 1 |
| Choroidal Neovascularization | 1 |
| Eye Diseases, Hereditary | 1 |
| Eye Neoplasms | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.